報價延遲最少15分鐘:2024/05/16 23:44 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.05 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.63/-1.69
|
|
企業價值
436.46M
|
| 資產負債 |
|
每股賬面淨值
1.15
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
3.60M
|
|
每股收益
0.11
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/05/16 23:44 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. |